Jared Holz, an analyst at Mizuho Securities, provided insights on the competitive landscape of the GLP-1 medication market during a recent appearance on the...
In New York, major developments in the pharmaceutical industry are making headlines. Novo Nordisk is grappling with ongoing challenges that have raised concerns about...
URGENT UPDATE: Novo Nordisk has just announced a significant restructuring plan that will unfold during the third quarter of 2023. This decision comes as...
Eli Lilly has entered into a significant collaboration with Superluminal, a machine learning-driven startup, aiming to advance research and development in obesity treatments. This...
URGENT UPDATE: UBS has officially downgraded its rating for Novo Nordisk, the renowned Danish pharmaceutical company behind the blockbuster weight-loss drugs Ozempic and Wegovy....
A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients...